Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

budralazine

Known as: 1(2H)-Phthalazinone, (1,3-dimethyl-2-butenylidene)hydrazone, 1-(2-(1,3-dimethyl-2-butenylidene)hydrazino)phthalazine, 4-Methyl-3-penten-2-one (1-phthalazinyl)hydrazone 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1991
1991
The present study was undertaken to elucidate the anti-tachycardic effect of a direct-acting vasodilator, budralazine, using an… Expand
1989
1989
We studied the effect of chronic antihypertensive treatment with budralazine on the lower blood pressure limit of cerebral blood… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
1986
1986
Budralazine was evaluated for its effect on the cerebral blood flow (CBF) in comparison with some antihypertensive drugs in… Expand
1983
1983
Intravenous injection of 1-[2-(1,3-dimethyl-2-butenylidene)hydrazino]phthalazine (budralazine) to anesthetized dogs resulted in… Expand
1981
1981
In renal hypertensive dogs, 1-[2-(1,3-dimethyl-2-butenylidene)hydrazino]phthalazine (budralazine) at doses of 1 and 2.5 mg/kg p.o… Expand
1981
1981
Cardiac presynaptic and vascular postsynaptic alpha-adrenergic effects of 1-[2-(1,3-dimethyl-2-butenylidene)hydrazino]phthalazine… Expand
1981
1981
Antihypertensive and general pharmacological properties of 1-[2-(1,3-dimethyl-2-butenylidene)hydrazino]phthalazine (budralazine… Expand
1979
1979
1. [14C]Budralazine (I) administered orally to normotensive and spontaneously hypertensive rats showed no significant difference… Expand
1978
1978
Antihypertensive and pharmacological properties of budralazine were examined in comparison with other antihypertensive drugs… Expand
1977
1977
The metabolic pathways of budralazine were studied in vivo and in vitro experiments and characterized as follows ; 1) 3-methyl-s… Expand